- Report
- March 2026
- 163 Pages
Germany
From €4415EUR$4,850USD£3,799GBP
- Report
- June 2025
- 88 Pages
North America
From €3140EUR$3,450USD£2,703GBP
- Report
- June 2025
- 106 Pages
Global
From €3140EUR$3,450USD£2,703GBP
- Report
- June 2020
- 464 Pages
Global
From €4460EUR$4,900USD£3,839GBP
- Report
- November 2025
- 107 Pages
Global
From €3500EUR$4,119USD£3,118GBP
- Report
- May 2023
- 121 Pages
Global
From €3500EUR$4,119USD£3,118GBP
- Report
- April 2024
- 132 Pages
Global
From €865EUR$950USD£744GBP
- Book
- December 2019
- 200 Pages
The Gene Panel market is a subset of the genomics industry that focuses on the development and sale of gene panels. These panels are collections of genes that are used to identify genetic variants associated with a particular disease or condition. They are used in clinical diagnostics, research, and drug development.
Gene panels are typically composed of hundreds to thousands of genes, and can be used to detect a wide range of genetic variants. They are often used to identify genetic markers associated with specific diseases, such as cancer, neurological disorders, and cardiovascular diseases.
The Gene Panel market is highly competitive, with a number of companies offering different types of panels. Companies in the market include Illumina, Thermo Fisher Scientific, Agilent Technologies, and Qiagen. Show Less Read more